Champignon Brands To Resume Trading Today

Champignon Brands (CSE: SHRM) is expected to resume trading today after what was a nearly year-long trading halt imposed by both the British Columbia Securities Commission and Ontario Securities Commission.

The company has seen the revocation of cease trade orders issued by the two commissions, effective April 22. Following the acceptance of a listing statement by the CSE, the company is now to resume trading on the Canadian Securities Exchange this morning.

A number of developments occurred during the time it was halted, including the restructuring of its corporate structure, the appointment of a new CFO and general counsel, as well as the development of its business units. The company currently operates a network of clinics that provides treatment for depression, while also conducting research and development on novel drug treatments.

Finally, the company also announced that it has seen voluntary contributions of capital from certain existing shareholders, resulting in their cap table seeing a decline in shares outstanding to that of $167.5 million.

Champignon Brands last traded at $0.89, and has been halted since June 19, 2020.


Information for this briefing was found via Sedar and the companies mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Champignon Appoints Dr Bill Wilkerson To Board Of Directors

Champignon Brands (CSE: SHRM) this morning continued its ongoing process of strengthening its board of...

Monday, May 25, 2020, 08:29:55 AM

Braxia Scientific Launches Multiple-Dose Psilocybin Clinical Trial for Treatment-Resistant Depression

Braxia Scientific Corp. (CSE: BRAX), formerly Champignon Brands, announced today that its clinical research and...

Friday, August 27, 2021, 08:20:00 AM

Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board

This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its...

Wednesday, May 6, 2020, 09:18:25 AM

Champignon Brands To Acquire Biotech Firm Novo Formulations

Champignon Brands (CSE: SHRM) announced today that they have signed a definitive agreement to acquire...

Thursday, March 19, 2020, 03:27:32 PM

Champignon Brands Latest Shroom Stock To IPO

Champignon Brands (CSE: SHRM) completed its initial public offering (IPO) late Friday night, with the...

Monday, March 2, 2020, 10:40:37 AM